Akebia Therapeutics Inc (AKBA) is down Monday morning, with the stock declining -4.92% in pre-market trading to 1.74.
AKBA's short-term technical score of 71 indicates that the stock has traded more bullishly over the last month than 71% of stocks on the market. In the Biotechnology industry, which ranks 92 out of 146 industries, the stock ranks higher than 80% of stocks.
Akebia Therapeutics Inc has risen 7.02% over the past month, closing at $1.62 on March 4. During this period of time, the stock fell as low as $1.37 and as high as $2.48. AKBA has an average analyst recommendation of Strong Buy. The company has an average price target of $4.33.
AKBA has an Overall Score of 86. Find out what this means to you and get the rest of the rankings on AKBA!
Akebia Therapeutics Inc has a Long-Term Technical rank of 94. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 6% of the market scoring higher. In the Biotechnology industry which is number 66 by this metric, AKBA ranks better than 66% of stocks.
